Gilead Sciences Inc
Stock Chart, Company Information, and Scan Results
$126.28(as of Jun 30, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Gilead Sciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$126.28
Ticker SymbolGILD
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees17,000
CountyUSA
Market Cap$158,772.0M
EBIDTA14,738.0M
10-Day Moving Average125.39
P/E Ratio17.19
20-Day Moving Average125.91
Forward P/E Ratio15.22
50-Day Moving Average129.38
Earnings per Share7.35
200-Day Moving Average128.21
Profit Margin29.04%
RSI47.87
Shares Outstanding1,241.6M
ATR3.43
52-Week High155.38
Volume6,646,508
52-Week Low105.01
Book Value23,431.0M
P/B Ratio6.76
Upper Keltner133.63
P/S Ratio5.33
Lower Keltner118.18
Debt-to-Equity Ratio133.63
Next Earnings Date08/05/2026
Cash Surplus-1,848.0M
Next Ex-Dividend DateUnknown
Add good karma to your portfolio with GILD. This research-based biopharmaceutical company is making the world a better place by developing and commercializing medicines for life-threatening diseases like HIV/AIDS, liver diseases, and cancer. Gilead’s HIV treatments, including Truvada and Atripla, have helped transform the chronic disease into a manageable condition. Their treatments are responsible for saving millions of lives.
Gilead Sciences Inc In Our Stock Scanner
As of Jun 30, 2026
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.